WHO vaccine-preventable diseases: monitoring system. 2019 global summary

Last updated 10-December-2019 (data as of 10-December-2019)
Next overall update June 2020
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 11'5101 Infant (under 12 months) mortality rate: 82
GDP / capita (US$): 17'6451 Child (under 5 years) mortality rate: 92

Population data in thousands3

  2018  2017  2016  2015  2014  2000  1990  1980 
Total population 4'999  4'950  4'899  4'848  4'795  3'962  3'119  2'390 
Births 70  70  71  72  72  76  86  72 
Surviving infants 69  70  71  71  71  75  84  70 
Pop. less than 5 years 354  356  357  358  358  396  416  322 
Pop. less than 15 years 1'066  1'068  1'071  1'074  1'080  1'235  1'111  880 
Female 15-49 years 2'643  2'633  2'621  2'608  2'594  2'106  1'595  1'226 

Number of reported cases

(Click for retrospective incidence data for Costa Rica)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  76  1'000 
Mumps
ChartChart
  127  54  75  419 
Pertussis
ChartChart
  36  58  23  20  31  23  75  960 
Polio*
ChartChart
 
Rubella
ChartChart
  86 
Rubella (CRS)
ChartChart
  46 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
  17 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Costa Rica)
Vaccine year result method % card seen                                                
BCG 2010  100  MICS   94  92  90  89  83  80  92  92  80 
DTP1 2010  99  MICS   94  95  99  96  93  91  90 
DTP3 2010  94  MICS   94  94  96  97  92  91  88  95  86 
IPV1          95  99  96  93  91 
HepB_BD          90  87  91  89 
HepB3 2010  93  MICS   94  98  97  97  92  91  89 
Hib3 2010  92  MICS   94  94  96  97  92  91  92 
JapEnc         
MCV1          94  96  93  93  95  82  90  60 
MCV2          99*  93  87  90  90 
MenA         
PCV1          96  99*  96  92 
PCV2          95  98  96  94  92 
PCV3 2010  93  MICS   94  96  96  94  83 
Pol3 2010  95  MICS   94  94  96  97  92  91  80  95  86 
Rota1         
RotaC         
RCV1          94  96  93  93  95 
TT2plus 2010  MICS   94  81  77 
PAB         
VAD1         
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid July 2020

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Costa Rica)
BCG
ChartChart
  92  90  89  83  80  92  92  80 
DTP1
ChartChart
  95  99  99  93  91  90  98  95 
DTP3
ChartChart
  94  96  97  92  91  88  95  86 
HepB3
ChartChart
  98  97  97  92  91  89 
HepB_BD
ChartChart
  90  87  91  90  89 
Hib3
ChartChart
  94  96  97  92  91  92 
IPV1
  95  99  96  93 
MCV1
ChartChart
  94  96  93  93  95  82  90  60 
MCV2
ChartChart
  93  93  87  90  90 
PCV3
ChartChart
  96  96  94  94  83 
Pol3
ChartChart
  94  96  97  92  91  80  95  86 
RCV1
ChartChart
  94  96  93  93  95  82  90 
RotaC
 

Click to download WHO-UNICEF coverage estimates data for PAB time series.
Click to download WHO-UNICEF coverage estimates data for HPV time series.

Number of districts in the country 81  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 79
From 80 to 89% 17
From 50 to 79% 4
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2018 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTaPHibIPV 2, 4, 6, 15 months; Yes
HepB_Adult 1st contact; +2, +6 months; Yes risk groups
HepB_Pediatric birth; 2, 6 months; Yes
HPV 10 years; +6 months; Yes females; from May 2019
Influenza_Adult >=60 years; Yes and adults with chronic conditions, pregnant women, healthcare workers, other risk groups
Influenza_Pediatric 6 months-5 years; Yes and children with chronic conditions
MMR 15 months; 7 years; Yes
Pneumo_conj 2, 4, 15 months; Yes
Pneumo_ps >60 years; Yes
Rabies Yes according to pre-exposure or post-exposure
Rotavirus 2, 4 months; Yes from May 2019
Td 10 years; Yes and a booster every 10 years
Tdap Yes 20 weeks expecting pregnant women, workers of the CCSS, health students
TdaPIPV 4 years; Yes
Varicella 15 months; Yes

Immunizaton indicators

Indicator Expected answer 2018  2017  2016  2015  2014  2013  2012 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  No  No 
What years does the MYP cover? number 2015-2020  2015-2020  2015-2020  2015-2020  2015-2020     
Nº of districts with microplans that include activities to raise immunization coverage number 81     

System performance

Total Nº districts in country number 81  81  81  81  81  81  81 
Nº districts with DTP3 coverage >=80% number 78  79  78  72  77  69 
% of districts with DTP3 coverage >=80% From 0 to 100% 96  98  96  89  95  85 
Nº districts with measles (MCV1) coverage >=95% number 31  44  39  54  37  37 
% of districts with MCV1 coverage >=95% From 0 to 100% 38  54  48  67  46  46 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes    No  No   
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  No    No  Yes   

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 100  100  100    100  100  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  No 

Sources

 1  "The 2019 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  UN Inter-agency Group for Child Mortality Estimation (https://childmortality.org/data)  
 3  "United Nations, Population Division. The World Population Prospects - the 2019 revision". New York, 2019.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.